Amneal ophthalmic solution (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Amneal ophthalmic solution (investigational), covering 2024-08-06 to 2024-08-06. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes [Phase 1]